Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Motor Activity 2Breast Neoplasms 2Weight Loss 1Uterine Cervical Dysplasia 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Obesity 1Insulin Resistance 1Infertility, Female 1Infections 1Cognitive Dysfunction 1

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 4Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Sugars 2Resistance Training 2Preoperative Exercise 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1adrenosterone 1Zoledronic Acid 1World Health Organization oral rehydration solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Insulin Resistance × lime × Clear all
NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Mỹ Đức Hospital

Phase 3 Unknown
188 enrolled
Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡